Argatroban Stroke Treatment - A Pilot Safety Study

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Ischemic Stroke
Interventions
DRUG

argatroban

Argatroban IV Infusion at 1mcg/kg/min for 48 hours.

Trial Locations (6)

35249

University of Alabama-Birmingham, Birmingham

70112

Tulane University, New Orleans

75390

University of Texas-Southwestern Dallas, Dallas

77030

Memorial Hermann Hospital-Medical Center, Houston

77074

Memorial Hermann Southwest Hospital, Houston

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT00268762 - Argatroban Stroke Treatment - A Pilot Safety Study | Biotech Hunter | Biotech Hunter